Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

By Santos W.R.   Paraguai de Souza E.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2554-2561

Elsevier

Access to resources Recommend Favorite

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)

By da Silva V.O.   Borja-Cabrera G.P.   Correia Pontes N.N.   de Souza E.P.   Luz K.G.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1082-1092

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation

By Wang J.   Zganiacz A.   Xing Z.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2887-2898

Elsevier

Access to resources Recommend Favorite

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

By Alimohammadian M.H.   Khamesipour A.   Darabi H.   Firooz A.   Malekzadeh S.   Bahonar A.   Dowlati Y.   Modabber F.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 174-180

Elsevier

Access to resources Recommend Favorite

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

By Momeni A.Z.   Jalayer T.   Emamjomeh M.   Khamesipour A.   Zicker F.   Ghassemi R.L.   Dowlati Y.   Sharifi I.   Aminjavaheri M.   Shafiei A.   Alimohammadian M.H.   Hashemi-Fesharki R.   Nasseri K.   Godal T.   Smith P.G.   Modabber F.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 466-472

Elsevier

Access to resources Recommend Favorite